Clinical Trial Update: Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease

View source ↗

Summary

A prospective cohort and biobank study on nonalcoholic fatty liver disease and related steatohepatitis (NAFLD/MASH/NASH) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Fondazione Epatocentro Ticino | Conditions: NAFLD, MASH | Status: RECRUITING